The research program, entitled "Novel Approaches to Treatment of Addiction and Depression using Animal Models" or NATAD Program, is spearheaded by Dr. Rohani Cena-Navarro of the University of the Philippines Manila - National Institutes of Health (UP-NIH). The program aims to find medications and solutions for addiction to toluene and depression.
The program is scheduled to continue until January 31, 2024, for further research and development.
In the initial project, scientists conducted a pilot study on male rats, investigating the effects of chronic unpredictable mild stress and carrying out a series of behavioral tests on the rats. This provided insight into addiction and depression.
The potential benefits and risks of providing a combination of psychobiotic and antidepressant drugs as treatment for those addicted to toluene are also currently being studied.
DOST Secretary Renato Solidum expressed his support for the NATAD Program. "The NATAD Program aligns with the DOST's commitment to advancing research and development that directly addresses the pressing needs of our society. Beyond projects on health and rehabilitation, DOST is also developing adhesive additives that lessen health hazards. This way, we encourage transformative changes that will benefit the health and safety of individuals, families, communities and even affect socio economic concerns in the country," said Solidum.
